LTFS
AMAG

Ladenburg Thalmann Financial Services’s AMAG Pharmaceuticals AMAG Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Sell
15
-381
-96% -$4.16K ﹤0.01% 5625
2019
Q3 		$5K Hold
396
– – ﹤0.01% 4730
2019
Q2 		$4K Hold
396
– – ﹤0.01% 4828
2019
Q1 		$5K Hold
396
– – ﹤0.01% 4706
2018
Q4 		$7K Hold
396
– – ﹤0.01% 4483
2018
Q3 		$8K Sell
396
-354
-47% -$8.06K ﹤0.01% 4417
2018
Q2 		$15K Hold
750
– – ﹤0.01% 4022
2018
Q1 		$15K Buy
750
+223
+42% +$3.77K ﹤0.01% 4022
2017
Q4 		$7K Hold
527
– – ﹤0.01% 4407
2017
Q3 		$10K Hold
527
– – ﹤0.01% 4106
2017
Q2 		$10K Sell
527
-162
-24% -$3.21K ﹤0.01% 4035
2017
Q1 		$16K Buy
689
+381
+124% +$9.12K ﹤0.01% 3711
2016
Q4 		$11K Buy
308
+63
+26% +$1.88K ﹤0.01% 3852
2016
Q3 		$6K Sell
245
-45
-16% -$1.13K ﹤0.01% 4106
2016
Q2 		$7K Sell
290
-172
-37% -$3.94K ﹤0.01% 3993
2016
Q1 		$11K Sell
462
-503
-52% -$11.9K ﹤0.01% 3667
2015
Q4 		$29K Buy
965
+19
+2% +$614 ﹤0.01% 2969
2015
Q3 		$37K Buy
946
+106
+13% +$6.58K ﹤0.01% 2680
2015
Q2 		$58K Buy
840
+494
+143% +$31.1K ﹤0.01% 2489
2015
Q1 		$19K Buy
346
+191
+123% +$9.1K ﹤0.01% 3225
2014
Q4 		$7K Buy
155
+140
+933% +$5.06K ﹤0.01% 3601
2014
Q3 		$0 Hold
15
– – ﹤0.01% 4089
2014
Q2 		$0 Hold
15
– – ﹤0.01% 4022
2014
Q1 		$0 Hold
15
– – ﹤0.01% 3895
2013
Q4 		$0 Sell
15
-3
-17% -$71 ﹤0.01% 3893
2013
Q3 		$0 Hold
18
– – ﹤0.01% 3869
2013
Q2 		$0 Buy
+18
New +$397 ﹤0.01% 3703

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AMAG Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its AMAG Pharmaceuticals (AMAG) stake by 96% in Q4 2019, selling an estimated $4.16K and leaving 15 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5625.

Ladenburg Thalmann Financial Services first reported a position in AMAG in Q2 2013 and has held it in 27 quarters since. The position peaked at $58K in Q2 2015. 134 funds tracked by Wall St. Rank hold AMAG as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 15 shares of AMAG Pharmaceuticals worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 381 AMAG Pharmaceuticals shares in Q4 2019, an estimated $4.16K.
  • AMAG Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5625 holding.
  • Ladenburg Thalmann Financial Services first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's AMAG Pharmaceuticals position peaked at $58K in Q2 2015.
  • 134 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.